View in EDS HTML Full Text PDF Full Text

Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.

Saved in:
Bibliographic Details
Title: Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.
Authors: Zuckermann, Marc1,2,3 (AUTHOR) m.zuckermann@kitz-heidelberg.de, He, Chen4 (AUTHOR), Andrews, Jared4 (AUTHOR), Bagchi, Aditi5 (AUTHOR), Sloan-Henry, Roketa6 (AUTHOR), Bianski, Brandon7 (AUTHOR), Xie, Jia7 (AUTHOR), Wang, Yingzhe8 (AUTHOR), Twarog, Nathaniel9 (AUTHOR), Onar-Thomas, Arzu10 (AUTHOR), Ernst, Kati J.1,3 (AUTHOR), Yang, Lei9 (AUTHOR), Li, Yong9 (AUTHOR), Zhu, Xiaoyan4 (AUTHOR), Ocasio, Jennifer K.4 (AUTHOR), Budd, Kaitlin M.4,11 (AUTHOR), Dalton, James12 (AUTHOR), Li, Xiaoyu12 (AUTHOR), Chepyala, Divyabharathi9 (AUTHOR), Zhang, Junyuan4 (AUTHOR)
Source: Molecular Cancer. 6/7/2024, Vol. 23 Issue 1, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14764598
DOI:10.1186/s12943-024-02027-6